Lifecore Biomedical Inc. (LFCR NASDAQ) stock market data APIs
$8.0664
0.08(1%)
as of June 30, 2025
Try our APIs with
free plan!
Lifecore Biomedical Inc. Financial Data Overview
Price chart is built with
Anychart
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Prev. Close
8.0664
Open
8.1454
High
8.4007
Low
7.9436
52 wk Range
3.6793-8.6299
Market Cap
303 M
Shares Outstanding
37 025 K
Revenue
130 M
EPS
-0.47
Beta
0.666
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lifecore Biomedical Inc. data using free add-ons & libraries
Get Lifecore Biomedical Inc. Fundamental Data
Lifecore Biomedical Inc. Fundamental data includes:
- Net Revenue: 130 M
- EBITDA: -3 488 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-04
- EPS/Forecast: -0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lifecore Biomedical Inc. News
New
Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy
(RTTNews) - Lifecore Biomedical, Inc. (LFCR) has entered a 10-year commercial manufacturing and supply agreement with an existing partner to advance a new ophthalmic treatment through clinical stages ...
Lifecore signs 10-year manufacturing deal with key ophthalmic client
CHASKA, Minn. - Lifecore Biomedical, Inc. (NASDAQ: LFCR), a $247 million market cap company with annual revenues of $130 million, has secured a new 10-year commercial manufacturing and supply agreemen...
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy
Lifecore Biomedical Inc. (NASDAQ:LFCR) recently presented its corporate strategy and financial performance, highlighting its transformation into a specialized contract development and manufacturing or...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
